NXT-10796
NXT-10796 is orally active, intestinally restricted EP4 receptor agonist[1].
Product Specifications
UNSPSC
12352005
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nxt-10796.html
Solubility
10 mM in DMSO
Smiles
O=C(NNC(C(O)=O)=O)CCCCCCN1[C@@H](/C=C/[C@@H](O)CC2=CC=CC=C2)CCC1=O
Molecular Formula
C23H31N3O6
Molecular Weight
445.51
References & Citations
[1]St-Onge M, et al. Discovery of NXT-10796, an orally active, intestinally restricted EP4 agonist prodrug for the treatment of inflammatory bowel disease. Bioorg Med Chem Lett. 2023;91:129351.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
